Vaxcell-Bio Therapeutics Co., Ltd. (KOSDAQ: 323990)

South Korea flag South Korea · Delayed Price · Currency is KRW
10,440
-280 (-2.61%)
Dec 19, 2024, 3:00 PM KST
-49.69%
Market Cap 229.93B
Revenue (ttm) 69.60M
Net Income (ttm) -10.43B
Shares Out 22.99M
EPS (ttm) -444.28
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 93,026
Open 10,400
Previous Close 10,720
Day's Range 10,380 - 10,570
52-Week Range 10,360 - 25,200
Beta n/a
Analysts n/a
Price Target n/a
Earnings Date n/a

About Vaxcell-Bio Therapeutics

Vaxcell-Bio Therapeutics Co., Ltd. develops and sells cancer immune cell therapy products in South Korea. The company was founded in 2010 and is headquartered in Hwasun-eup, South Korea. [Read more]

Industry Biological Products, Except Diagnostic Substances
Founded 2010
Country South Korea
Stock Exchange KOSDAQ
Ticker Symbol 323990
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.